购物车
全部删除
您的购物车当前为空
WEHI-539 hydrochloride is a selective Bcl-XL inhibitor (IC50: 1.1 nM).

WEHI-539 hydrochloride is a selective Bcl-XL inhibitor (IC50: 1.1 nM).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 889 | 5日内发货 | |
| 5 mg | ¥ 1,710 | 5日内发货 | |
| 25 mg | ¥ 5,900 | 10-14周 | |
| 50 mg | ¥ 7,670 | 10-14周 | |
| 100 mg | ¥ 11,800 | 10-14周 |
| 产品描述 | WEHI-539 hydrochloride is a selective Bcl-XL inhibitor (IC50: 1.1 nM). |
| 靶点活性 | BCL-XL:1.1 nM |
| 体外活性 | WEHI-539 hydrochloride is a selective Bcl-XL inhibitor. WEHI-539 augments NSC 241240 induced caspase 3/7 activity, PARP cleavage and annexin V labelling. WEHI-539 as a single agent causes noticeable PARP cleavage in Ovcar-4 (5 μM in Ovcar-4.) and Ovsaho (1 μM in Ovsaho) cells[2]. |
| 分子量 | 620.18 |
| 分子式 | C31H30ClN5O3S2 |
| CAS No. | 2070018-33-4 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (80.62 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2.5 mg/mL (4.03 mM), Sonication is recommeded. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多